首页> Thrombosis and haemostasis> Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B.

Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B.

导出 LinkOut

翻译打印收藏纠错

第一作者： David E,Schmidt

第一单位： Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.;Paediatric Coagulation, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

作者： David E,Schmidt ^[1] ; Åsa,Truedsson ^[2] ; Annelie,Strålfors ^[3] ; Johanne Andersen,Hojbjerg ^[4] ; Nida,Soutari ^[3] ; Margareta,Holmström ^[5] ; Susanna,Ranta ^[1] ; Anna,Letelier ^[6] ; Annette,Bowyer ^[7] ; Rolf,Ljung ^[6] ; Jovan,Antovic ^[3] ; Maria,Bruzelius ^[8]

作者单位： Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.;Paediatric Coagulation, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. ^[1] Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden. ^[2] Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. ^[3] Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.;Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. ^[4] Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.;Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. ^[5] Department of Clinical Sciences, Lund University, Lund, Sweden. ^[6] Department of Coagulation, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom. ^[7] Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.;Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. ^[8]